00656.HK --


More News

  • Fidelidade and Fosun attended Web Summit and reinforced its commitment to collaborative innovation with Startups


    -Contributing to the development of an innovation ecosystem-During the main meeting on technology, entrepreneurship and innovation, Startups will be able to submit pre-applications for the 2023 edition of Protechting.Lisbon, 1-4 November 2022 – Fidelidade and Fosun had once again presented at the Web Summit in Portugal, the largest and most important i

  • Fosun Attends Forum Themed “Promoting Macao as a Platform Connecting China and Portuguese-speaking Countries” at the CIIE


    Fostering Economic and Trade Development Between China and Portuguese-speaking Countries (PSCs)

  • Fosun Participates in the CIIE for the Fifth Consecutive Year with the Debut of Innovative Products in China


    The 5th China International Import Expo (hereinafter referred to as the “CIIE”) will be held in Shanghai from 5 November to 10 November. Fosun will participate in the CIIE for the fifth consecutive year with its overseas member companies and partners from the global pharmaceutical and health industry, presenting a variety of China's first and industry-leading medical devices and innovative drugs to showcase Fosun's latest achievements in technology and innovation and global industrial operations and promote more "exhibits" to launch as “products” in China.

  • “Fosun Family” Run To Love 2022 | Together for a Better Life


    Time flies, and in the blink of an eye, Fosun celebrates its 30th anniversary this year. Over the past 30 years, Fosun has always adhered to the original aspiration of "Contribution to Society", encouraged employees to participate in public welfare activities, and launched a number of public welfare projects to practice corporate social responsibility. This year's "Fosun Family" Run to Love kicked off in August, leaving footprints all over the world. Let us take a look at the Run to Love event!

  • Fosun Pharma Announces Results for the First Three Quarters of 2022


    Stable Growth in Revenue and Recurring Income, Achieving a Year-on-year Increase of the Net Profit (After Extraordinary Gain or Loss) Attributable to Shareholders of the Listed Company of 15.51%, and Promoting the Internationalization Strategy Consistently(October 30, 2022, Shanghai, China) On October 30, 2022,Shanghai Fosun Pharma (Group